"covishield"

The trial will be conducted on 1,500 subjects as part of the randomised, double-blind, parallel-group, placebo-controlled study in India

A total of 14 centres have been identified for vaccination in Karimnagar, Jagitial, Peddapalli and Rajanna-Sircilla districts on the first day of vaccination process from Saturday

The list of AEFI for Covishield include injection site tenderness, injection site pain, headache fatigue, myalgia, malaise, pyrexia, chills and arthralgia nausea

Officials also pointed out that Covaxin, the Covid vaccine developed by Bharat Biotech, will not be administered to anybody on the first day

"Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible"

The Minister wrote to all the Members of Legislative Assembly appealing them to take part in the vaccine administrative drive enthusiastically

Suggests advance arrangements be made to provide medical treatment if one develops a reaction

New Delhi: The much-anticipated inoculation programme against Covid-19 in the country is expected to begin by January 12, said government sources. “In all likelihood, the Covid immunisation drive is expected to start early next week. Considering the preparations, the roll-out programme may start on January 11 or latest by January 12,” a senior government official […]

Lauding the scientists and technicians for the 'Made in India' vaccines, he said the country is proud of them

"SII has applied for emergency use authorisation to DCGI. The application will be reviewed by the expert committee and after that final call will be taken," a senior government official confirmed ANI.

The Oxford-AstraZeneca vaccine is being made in partnership with Serum Institute.

SII and ICMR are conducting phase II/III clinical trial of the vaccine at 15 different centres across the country.